Instituto Portugues de Oncologia do Porto Francisco Gentil (IPOPFG, EPE)

Porto 4200-072

0 studies enrolling now · 2 studies all time

What they study most

Chronic Lymphocytic Leukemia, Ovarian Cancer

Studies at this site

• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) — Completed